15550293|t|The neuropsychiatry of Parkinson's disease and related disorders.
15550293|a|Parkinson's disease is associated with classical Parkinsonian features that respond to dopaminergic therapy. Neuropsychiatric sequelae include dementia, major depression, dysthymia, anxiety disorders, sleep disorders, and sexual disorders. Panic attacks are particularly common. With treatment, visual hallucinations, paranoid delusions, mania, or delirium may evolve. Psychosis is a key factor in nursing home placement, and depression is the most significant predictor of quality of life. Clozapine may be the safest treatment for psychotic features, but more research is needed to establish the efficacy of antidepressant treatments. Dementia with Lewy bodies, the second most common dementia in the elderly, may present in association with systematized delusions, depression, or RBD. Early evidence suggests the utility of rivastigmine, donepezil, low-dose olanzapine, and quetiapine in treating DLB. Parkinson-plus syndromes generally lack a good response to dopaminergic treatment and evidence additional features, including dysautonomia, cerebellar and pontine features, eye signs, and other movement disorders. MSA is associated with dysautonomia and RBD. SND (MSA-P) is associated with frontal cognitive impairments, but dementia, psychosis, and mood disorders have not been strikingly apparent unless additional pathological findings are present. In SDS (MSA-A), impotence is almost ubiquitous; urinary incontinence is frequent; depression is occasional, and sleep apnea should be treated to avoid sudden death during sleep. OPCA neuropsychiatric correlates await further definition. Progressive supranuclear palsy neuropsychiatric features include apathy, subcortical dementia, pathological emotionality, mild depression and anxiety, and lack of appreciable response to donepezil. CBD usually is recognized by early frontal dementia with ideomotor apraxia, often in the right upper extremity, attended later by poorly responsive unilateral Parkinsonism, with additional signs including cortical reflex myoclonus, limb dystonia, alien limb, oculomotor apraxia when asked to look horizontally, depression, personality changes, and, occasionally, Kluver-Bucy syndrome. The neuropsychiatry of FTDP-17 involves apraxia, executive impairment, personality changes, hyperorality, and occasional psychosis. Future research in these Parkinsonian disorders should target the characterization of neuropsychiatric sequelae and their treatment.
15550293	23	42	Parkinson's disease	Disease	MESH:D010300
15550293	66	85	Parkinson's disease	Disease	MESH:D010300
15550293	115	127	Parkinsonian	Disease	MESH:D010300
15550293	153	165	dopaminergic	Chemical	MESH:D004298
15550293	175	200	Neuropsychiatric sequelae	Disease	MESH:D001523
15550293	209	217	dementia	Disease	MESH:D003704
15550293	219	235	major depression	Disease	MESH:D003865
15550293	237	246	dysthymia	Disease	MESH:D019263
15550293	248	265	anxiety disorders	Disease	MESH:D001008
15550293	267	282	sleep disorders	Disease	MESH:D012893
15550293	288	304	sexual disorders	Disease	MESH:D012734
15550293	306	319	Panic attacks	Disease	MESH:D016584
15550293	361	382	visual hallucinations	Disease	MESH:D006212
15550293	384	402	paranoid delusions	Disease	MESH:D010259
15550293	404	409	mania	Disease	MESH:D001714
15550293	414	422	delirium	Disease	MESH:D003693
15550293	435	444	Psychosis	Disease	MESH:D011618
15550293	492	502	depression	Disease	MESH:D003866
15550293	557	566	Clozapine	Chemical	MESH:D003024
15550293	599	617	psychotic features	Disease	MESH:D019967
15550293	703	728	Dementia with Lewy bodies	Disease	MESH:D020961
15550293	753	761	dementia	Disease	MESH:D003704
15550293	823	832	delusions	Disease	MESH:D063726
15550293	834	844	depression	Disease	MESH:D003866
15550293	849	852	RBD	Disease	
15550293	893	905	rivastigmine	Chemical	MESH:D000068836
15550293	907	916	donepezil	Chemical	MESH:D000077265
15550293	927	937	olanzapine	Chemical	MESH:D000077152
15550293	943	953	quetiapine	Chemical	MESH:D000069348
15550293	966	969	DLB	Disease	MESH:D020961
15550293	971	995	Parkinson-plus syndromes	Disease	MESH:D010302
15550293	1030	1042	dopaminergic	Chemical	MESH:D004298
15550293	1097	1109	dysautonomia	Disease	MESH:D054969
15550293	1165	1183	movement disorders	Disease	MESH:D009069
15550293	1185	1188	MSA	Disease	MESH:C537381
15550293	1208	1220	dysautonomia	Disease	MESH:D054969
15550293	1225	1228	RBD	Disease	
15550293	1230	1233	SND	Disease	
15550293	1235	1240	MSA-P	Disease	MESH:C537381
15550293	1261	1290	frontal cognitive impairments	Disease	MESH:D003072
15550293	1296	1304	dementia	Disease	MESH:D003704
15550293	1306	1315	psychosis	Disease	MESH:D011618
15550293	1321	1335	mood disorders	Disease	MESH:D019964
15550293	1426	1429	SDS	Disease	MESH:D000081003
15550293	1431	1436	MSA-A	Disease	MESH:C537381
15550293	1439	1448	impotence	Disease	MESH:D007172
15550293	1471	1491	urinary incontinence	Disease	MESH:D014549
15550293	1505	1515	depression	Disease	MESH:D003866
15550293	1535	1546	sleep apnea	Disease	MESH:D012891
15550293	1574	1586	sudden death	Disease	MESH:D003645
15550293	1601	1605	OPCA	Disease	MESH:D020754
15550293	1660	1690	Progressive supranuclear palsy	Disease	MESH:D013494
15550293	1725	1731	apathy	Disease	
15550293	1733	1753	subcortical dementia	Disease	MESH:D015140
15550293	1787	1797	depression	Disease	MESH:D003866
15550293	1802	1809	anxiety	Disease	MESH:D001007
15550293	1847	1856	donepezil	Chemical	MESH:D000077265
15550293	1858	1861	CBD	Disease	OMIM:303800
15550293	1893	1909	frontal dementia	Disease	MESH:D003704
15550293	1915	1932	ideomotor apraxia	Disease	MESH:D020240
15550293	2017	2029	Parkinsonism	Disease	MESH:D010302
15550293	2079	2088	myoclonus	Disease	MESH:D009207
15550293	2095	2103	dystonia	Disease	MESH:D004421
15550293	2117	2135	oculomotor apraxia	Disease	MESH:C537423
15550293	2169	2179	depression	Disease	MESH:D003866
15550293	2181	2200	personality changes	Disease	MESH:D010554
15550293	2221	2241	Kluver-Bucy syndrome	Disease	MESH:D020232
15550293	2266	2273	FTDP-17	Disease	MESH:D057180
15550293	2283	2290	apraxia	Disease	MESH:D001072
15550293	2292	2312	executive impairment	Disease	MESH:D060825
15550293	2314	2333	personality changes	Disease	MESH:D010554
15550293	2335	2347	hyperorality	Disease	
15550293	2364	2373	psychosis	Disease	MESH:D011618
15550293	2400	2422	Parkinsonian disorders	Disease	MESH:D010300
15550293	2461	2486	neuropsychiatric sequelae	Disease	MESH:D001523
15550293	Negative_Correlation	MESH:D000069348	MESH:D020961
15550293	Negative_Correlation	MESH:D000077152	MESH:D020961
15550293	Negative_Correlation	MESH:D003024	MESH:D019967
15550293	Negative_Correlation	MESH:D003024	MESH:D011618
15550293	Association	MESH:D000069348	MESH:D010300
15550293	Negative_Correlation	MESH:D000077265	MESH:D020961
15550293	Negative_Correlation	MESH:D000077265	MESH:D013494
15550293	Association	MESH:D000077265	MESH:D010300
15550293	Negative_Correlation	MESH:D000068836	MESH:D020961
15550293	Negative_Correlation	MESH:D004298	MESH:D010300
15550293	Negative_Correlation	MESH:D004298	MESH:D003865

